The deficit between cost and value widened by £5,750 to £100,900 and the
deficit to injection amount went up to £37,391. Total portfolio value dropped
to £105,136 and is looking like it may go back below £100k.
The biggest loser was CWR:Ceres Power which must be a traders dream. They dropped 16% to go 41% down after a recent rally which has completely broken down.
The biggest loser was CWR:Ceres Power which must be a traders dream. They dropped 16% to go 41% down after a recent rally which has completely broken down.
IPX:Impax Asset Management dropped 9%, part of which was going ex-dividend,
but the dividend definitely isn't 9%.
AFC:AFC Energy was a recent speculative purchase and it appears a bad one,
as it dropped 7% this week to go 10% down.
OPTI:Optibiotix had another week with no news of interest to anyone and
dropped 7% accounting for over £4,000 of this week's losses.
BARC:Barclays looked like they may finally go into profit but fell 6% this
week and are now back to 15% down.
CAML:Cental Asia Metals just keeps dropping despite them having tons of
cash, no debt and a huge dividend. When my pension transfer lands in a few
weeks I'll be spending all of it on this. They fell 6% this week.
CAPD:Capital dropped 6% and is now 26% down.
BLU:Blue Star Capital dropped 5% which is meaningless because it's
worthless anyway.
EDV:Endeavour Mining continued the drastic decline by another 5% to go 36% down, which shouldn't happen to a FTSE 100 company.
PAF:Pan African Resources dropped 5% from profit to loss.
There was precious little good news, but POLY:Polymetal climbed 5% after a
massive drop last week, but are still 79% down.
Share of the week was ASHM:Ashmore Group which climbed an impressive 10%
after a good trading update. They are still 17% down, but in a much better
position to continue back into profit.
Here's the ISA and shares portfolio after week 28 of year 9.
| Weekly Change | |||
| Cash | £62.84 | -£3.75 | |
| Portfolio cost | £99,231.92 | +£0 | |
|
Portfolio sell value (bid price-commission) |
£48,102.24 | (-51.5%) | -£2,803.52 |
| Potential profits | £1,937.60 | -£396.38 | |
| Yr 9 Dividends | £202.72 | +£0 | |
| Yr 9 Interest | £3.29 | +£0 | |
| Yr 9 Profit from sales | £11.13 | +£0 | |
| Yr 9 proj avg monthly profit | £26.48 | (0.4%) | -£1.58 |
| Total Dividends | £12,114.15 | +£0 | |
| Total Interest | £5.22 | +£0 | |
| Total Profit from sales | £17,309.66 | +£0 | |
| Average monthly cash profit | £283.08 | (4.8%) | -£0.67 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 41% | +0% |
Cash dropped from ISA fee, huge drop in value and all potential profits drop thanks to OPTI:Optibiotix. The value fell below 50% of cost so has changed to crimson, which is a very sad moment.
Horrible
Desperate
The SIPP looks like this after week 428 overall and week 12 of year 9.
| Weekly Change | ||||
| Cash | £399.50 | +£251.68 | ||
| Portfolio cost | £104,266.40 | +£0 | ||
| Portfolio sell value (bid price - commission) | £55,386.44 | (-46.9%) | -£2,905.44 | |
| Potential profits | £778.10 | -£29.99 | ||
| Yr 9 Dividends | £105.13 | +£18.34 | ||
| Yr 9 Interest | £1.10 | +£0 | ||
| Yr 9 Profit from sales | £3,373.97 | +£0 | ||
| Yr 9 proj avg monthly profit | £1,237.49 | (21.4%) | -£111.84 | |
| Total Dividends | £14,740.01 | +£18.34 | ||
| Total Interest | £7.03 | +£0 | ||
| Total Profit from sales | £14,209.87 | +£0 | ||
| Average monthly cash profit | £280.92 | (4.9%) | -£0.64 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 40% | +0% |
My monthly investment cash got added, plus an £18 dividend from AJB:AJ Bell and minus SIPP charges. Huge drop in value but much smaller drop in potential profit, mainly caused by PAF:Pan African Resources going into loss.
Similar to ISA
Similarly desperate to ISA
The trading account looks like this after week 394 overall and week 30 of year 8.
Everything fell in value except SBTX:SkinBioTherapeutics which stayed the same. Value fell by £41 and all looking pretty shocking.
I'm sure a few weeks ago I said it looks a bit flat. Not so much now!
The trend line is almost flat. Next week it will be pointing down.
All my major holdings are in an utter mess. There's absolutely no support for the share prices and no forward looking investment for the future. I still believe in them but the market doesn't. The alternative is that the market makers are controlling the share prices for their own ends. I don't know how to predict or counter that kind of manipulation, so all I can do is maintain a long term view and be patient. It just feels like an awfully long wait.
| Weekly Change | |||
| Cash | £0.07 | +£0 | |
| Portfolio cost | £2,076.23 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,185.53 | (-42.9%) | -£41.40 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £8.56 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £42.26 | (+24.4%) | -£1.45 |
| Dividends | £68.66 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.36 | (-3.7%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Everything fell in value except SBTX:SkinBioTherapeutics which stayed the same. Value fell by £41 and all looking pretty shocking.
I'm sure a few weeks ago I said it looks a bit flat. Not so much now!
The trend line is almost flat. Next week it will be pointing down.
All my major holdings are in an utter mess. There's absolutely no support for the share prices and no forward looking investment for the future. I still believe in them but the market doesn't. The alternative is that the market makers are controlling the share prices for their own ends. I don't know how to predict or counter that kind of manipulation, so all I can do is maintain a long term view and be patient. It just feels like an awfully long wait.
No comments:
Post a Comment